Abstract
Monoclonal antibodies are unique binding molecules with a high specificity for their target. This makes them a very powerful tool for research, diagnostic and therapeutic applications. Modifications of structure and effector functions as well as a faster biotechnical production lead to an extended application in biomedicine.
Similar content being viewed by others
Literatur
Kirk SJ, Cliff JM, Thomas A et al. (2009) Biogenesis of secretory organelles during B cell differentiation. J Leukoc Biol 87:245–255
Köhler G, Milstein C (1976) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497
De Marco A (2011) Biotechnological applications of recombinant single-domain antibody fragments. Microb Cell Fact 10:44–58
Berges BK, Rowan MR (2011) The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment. Retrovirology 8:65–84
Wand I, Holzlöhner P, Neupert S et al. (2011) Cooperation of dendritic cells with naiive lymphocyte populations to induce the generation of antigen-specific antibodies in vitro. J Biotechnol 156:173–181
Van Bockstaele F, Holz JB, Revets H (2009) The development of nanobodies for therapeutic applications. Curr Opin Investig Drugs 10:1212–1224
Micheel B (2003) Monoklonale Antikörper. In: Ganten D, Ruckpaul K (Hrsg) Grundlagen der Molekularen Medizin. Springer-Verlag, Berlin. 494–523
Author information
Authors and Affiliations
Corresponding author
Additional information
Pamela Holzlöhner Jahrgang 1982. 2000–2004 Biotechnologiestudium an den Universitäten Leipzig und Wollongong, Australien. 2009 Promotion. 2008–2012 Postdoc in der Nachwuchsgruppe „Antikörper-Technologien“, Universität Potsdam.
Katrin Messerschmidt Jahrgang 1979. 1999–2004 Biochemiestudium an der Universität Potsdam. 2008 Promotion. 2008–2012 Postdoc in der Nachwuchsgruppe „Antikörper-Technologien“, Universität Potsdam.
Katja Heilmann Jahrgang 1978. 1996–2002 Biologiestudium an den Universitäten Rostock und Humboldt, Berlin. 2006 Promotion, anschließend Postdoc an der Charité — Universitätsklinikum Berlin. Seit 2008 Leiterin der InnoProfile-Nachwuchsgruppe „Antikörper-Technologien“ an der Universität Potsdam.
Rights and permissions
About this article
Cite this article
Heilmann, K., Messerschmidt, K. & Holzlöhner, P. Monoklonale Antikörper — Herstellung und Verwendung. Biospektrum 18, 167–169 (2012). https://doi.org/10.1007/s12268-012-0160-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12268-012-0160-5